ID: ALA4077099

Max Phase: Preclinical

Molecular Formula: C26H44N2O3

Molecular Weight: 432.65

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCc1nc(OC2CCC2)nc(OC2CCC2)c1O

Standard InChI:  InChI=1S/C26H44N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-20-23-24(29)25(30-21-16-14-17-21)28-26(27-23)31-22-18-15-19-22/h21-22,29H,2-20H2,1H3

Standard InChI Key:  KJRZCMSAMBMOGJ-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 432.65Molecular Weight (Monoisotopic): 432.3352AlogP: 7.29#Rotatable Bonds: 17
Polar Surface Area: 64.47Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.55CX Basic pKa: 3.97CX LogP: 8.69CX LogD: 8.69
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.26Np Likeness Score: 0.16

References

1. Chevalier A, Khdour OM, Schmierer M, Bandyopadhyay I, Hecht SM..  (2017)  Influence of substituent heteroatoms on the cytoprotective properties of pyrimidinol antioxidants.,  25  (5): [PMID:28189395] [10.1016/j.bmc.2017.01.030]

Source